| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.087 | 0.08 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.076 | 0.1 |